| Application no. and date | 18736860.0 (espacenet) (Federated) (European Patent Register), 20180629 | | Patent/reg. no. and date | DK/EP 3645034, 20230830 | | Publication date | 20200506 | | Priority no. and date | US 201762526377 P, 20170629 | | EP pub. no. and date |
EP 3645034 20200506 | | Effective date | | | Applicant/owner | CSL Behring Lengnau AG, Biotech Innovation Park
2543 Lengnau BE, CH | | Applicant ref. no. | PV1718DKEP | | Inventor | JACOBS, Iris, 424 Ashton Drive
King of Prussia, PA 19406, US,
BENSEN-KENNEDY, Debra, 80 Horseshoe Point
Phoenixville, PA 19460, US,
LI, Yanyan, 3802 Forest Hill Drive
Furlong, PA 18925, US,
VOIGT, Christine, 315 Highland Avenue
Devon, PA 19333, US | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 38/48 (2006.01) , C12N 9/64 (2006.01) | | Title | 21-DAGES DOSERINGSREGIMEN FOR FUSIONSPROTEINER OMFATTEN-DEFAKTOR IX OG HUMAN ALBUMIN TIL PROFYLAKTISK BEHANDLING AF HÆMOFILI OG FREMGANGSMÅDER HERAF | | Int. application no. | EP2018067523 | | Int. publication no. | WO2019002532 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
